Products

Semaglutide is a GLP-1 receptor agonist (incretin mimetic) used to treat type 2 diabetes and obesity. It stimulates insulin release, suppresses glucagon secretion, slows gastric emptying, and reduces appetite. 

Administered once weekly via subcutaneous injection, it helps lower blood sugar and promote weight loss.